Alector (ALEC) Other Non Operating Income (2018 - 2026)
Alector's (ALEC) quarterly Other Non Operating Income came in at $2.0 million in Q1 2026, down 52.91% year-on-year from $4.2 million in Q1 2025, and up 142.84% on a QoQ basis from -$4.6 million in Q4 2025.
Alector (ALEC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Other Non Operating Income data on file, last reported at $2.0 million in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 52.91% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 82.79% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 76.47% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $2.0 million, up from -$4.6 million in the prior quarter.
- Over the last five years, Other Non Operating Income for ALEC reached as high as $7.7 million in Q4 2023 and fell as low as -$4.6 million in Q4 2025.
- Historically, Other Non Operating Income has averaged $4.0 million across 5 years, with a median of $4.2 million in 2025.
- Across the five-year window, Other Non Operating Income soared 3001.65% in 2022 and plunged 188.9% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $3.8 million in 2022, then jumped by 105.81% to $7.7 million in 2023, then plunged by 32.38% to $5.2 million in 2024, then plunged by 188.9% to -$4.6 million in 2025, then surged by 142.84% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $2.0 million in Q1 2026, -$4.6 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | -4.64 Mn |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 6.21 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 7.72 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 178,000.00 |